vs
Side-by-side financial comparison of NOVO NORDISK A S (NVO) and RedHill Biopharma Ltd. (RDHL). Click either name above to swap in a different company.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
RedHill Biopharma Ltd. is a specialty biopharmaceutical firm focused on developing and commercializing innovative therapeutics for gastrointestinal disorders, inflammatory conditions, and infectious diseases. It operates mainly in North American and European markets, delivering prescription treatments for unmet clinical needs and partnering with healthcare stakeholders to expand product access.
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
